Modifications of the homeostasis model assessment of insulin resistance index with age

Acta Diabetologica

Volumn 51, Issue 6, 2014, Pages 917-925

  Soriguer, Federico ^a,b   Colomo, Natalia ^a,b   Valdés, Sergio ^a,b   Goday, Alberto ^c   Rubio Martín, Elehazara ^a,b   Esteva, Isabel ^a,b   Castaño, Luis ^a,d   Ruiz de Adana, María Soledad ^a,b   Morcillo, Sonsoles ^a,e   Calle, Alfonso ^f   García Fuentes, Eduardo ^a,b   Catalá, Miguel ^a,g   Gutiérrez Repiso, Carolina ^a,b   Delgado, Elias ^h   Gomis, Ramón ^a,i   Ortega, Emilio ^a,j   Rojo Martínez, Gemma ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^h HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

Aging; HOMA IR; Insulin resistance; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; AGE; AGED; AGING; ARTICLE; BODY MASS; DIABETES MELLITUS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; RISK FACTOR; SPAIN; ADOLESCENT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; HEALTH STATUS INDICATOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; THEORETICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS INDICATORS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MODELS, THEORETICAL; OBESITY; PREVALENCE; SPAIN; YOUNG ADULT;

EID: 84919422689     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0523-5     Document Type: Article

References (38)

1. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM et al (2006) Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: national Health and Nutrition Examination Survey 1999–2002. Diabetes Care 29:1263–1268
2. Chen M, Bergman RN, Pacini G, Porte D Jr (1985) Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab 60:13–20
3. Jackson RA, Hawa MI, Roshania RD, Sim BM, DiSilvio L, Jaspan JB (1988) Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes 37:119–129
4. Jackson RA (1990) Mechanisms of age-related glucose intolerance. Diabetes Care 13:S9–S19
5. Paolisso G, Scheen A, Lefebvre P (1995) Glucose handling, diabetes and ageing. Horm Res 43:52–57
6. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D (1999) Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 29:758–769
7. Ryan AS (2000) Insulin resistance with aging: effects of diet and exercise. Sports Med 30:327–346
8. Broughton DL, Taylor R (1991) Review: deterioration of glucose tolerance with age: the role of insulin resistance. Age Ageing 20:221–225
9. Sakurai T, Iimuro S, Araki A, Umegaki H, Ohashi Y, Yokono K et al (2010) Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Gerontology 56:141–149
10. Imbeault P, Prins JB, Stolic M, Russell AW, O`Moore-Sullivan T, Deprés JP et al (2003) Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care 26:480–484
11. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U (1996) Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45:947–953
12. Gayoso-Diz P, Otero-González A, Rodríguez-Alvarez MX, Cude F, Cadarso-Juárez C, García F et al (2011) Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract 94:146–155
13. Fink RI, Kolterman OG, Griffin J, Olefsky JM (1983) Mechanisms of insulin resistance in aging. J Clin Invest 71:1523–1535
14. Yki-Jarvinen H, Kiviluoto T, Nikkila EA (1986) Insulin binding and action in adipocytes in vitro in relation to insulin action in vivo in young and middle-aged subjects. Acta Endocrinol (Copenh) 113:88–92
15. Reed MJ, Reaven GM, Mondon CE, Azhar S (1993) Why does insulin resistance develop during maturation? J Gerontol 48:139–144
16. Ivy JL, Young JC, Craig BW, Kohrt WM, Holloszy JO (1991) Ageing, exercise and food restriction: effects on skeletal muscle glucose uptake. Mech Ageing Dev 61:123–133
17. Silver AJ, Guillen CP, Kahl MJ, Morley JE (1993) Effect of aging on body fat. J Am Geriatr Soc 41:211–213
18. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F (1986) Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 44:739–746
19. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473–481
20. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R et al (2012) Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 55:88–93
21. Soriguer F, Rojo-Martínez G, Almaraz MC, Esteva I, Ruiz de Adana MS, Morcillo S et al (2008) Incidence of type 2 diabetes in Southern Spain (Pizarra Study). Eur J Clin Invest 38:126–133
22. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
24. Scheen AJ (2005) Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Diabetes Metab 31:5S27–5S34
25. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK et al (2001) Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 24:925–932
26. Houmard JA, Weidner MD, Dolan PL, Leggett-Frazier N, Gavigan KE, Hickey MS et al (1995) Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes 44:555–560
27. Paolisso G, Ammendola S, Del Buono A, Gambardella A, Riondino M, Tagliamonte MR et al (1997) Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab 82:2204–2209
28. Soriguer F, Rubio-Martín E, Fernández D, Valdés S, García-Escobar E, Martín-Núñez GM et al (2012) Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study. Eur J Clin Invest 42:79–85
29. Forbes A, Elliott T, Tildesley H, Finegood D, Meneilly GS (1998) Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes 47:1915–1919
30. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1989) Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356–1359
31. Mercurio V, Carlomagno G, Fazio V, Fazio S (2012) Insulin resistance: is it time for primary prevention? World J Cardiol 4:1–7
32. de Mello VD, Lindström J, Eriksson J, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Sundwall J et al (2012) Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study. Diabetes Care 35:211–217
33. Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, Laakso M et al (2011) Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia 54:1507–1516
34. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modelling. Diabetes Care 27:1487–1495
35. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T et al (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818–822
36. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V et al (2011) Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 35:971–981
37. Soriguer F, Rojo-Martínez G, Goday A, Bosch-Comas A, Bordiú E, Caballero-Díaz F et al (2013) Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study. Eur J Clin Nutr 67:911–916
38. Rojo-Martínez G, Esteva I, de Adana SR, Catalá M, Merelo MJ, Tinahones F et al (2004) Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res Clin Pract 65:247–256